The U.S. Food and Drug Administration’s risk-benefit assessment in connection with Pfizer’s application for emergency use of its COVID vaccine for children 5 to 11 describes only relative risks in an older population. It ignores absolute risk and also the standard calculation for measuring a drug’s effectiveness — Number Needed To Vaccinated (NNTV). …read more
Source: Sott health news feed
Thanks! Share it with your friends!
Tweet
Share
Pin It
LinkedIn
Google+
Reddit
Tumblr